Ipsen S.A. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ipsen S.A. (Ipsen or 'the company') is a pharmaceutical company that offers drugs in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. Ipsen provides products for neurodegenerative pathologies, and rheumatology diseases and gastrointestinal disorders. It distributes its drugs to various public hospitals. Ipsen sells its products under Adrovance, Dysport, Decapeptyl, Adenuric, NutropinAq, Smecta, Somatuline and Tanakan brand names. Ipsen has business operations in North America, Asia and Europe. The company is headquartered in Boulogne-Billancourt, Paris, France.
Scope
Detailed information on Ipsen S.A. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Ipsen S.A. in the form of a SWOT analysis
An in-depth view of the business model of Ipsen S.A. including a breakdown and examination of key business segments
Intelligence on Ipsen S.A.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Ipsen S.A., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Ipsen S.A. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Ipsen S.A. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Ipsen S.A.'s business structure, strategy and prospects.
Company Snapshot
Ipsen S.A.: Company Overview
Ipsen S.A.: Overview and Key Facts
Ipsen S.A.: Overview
Ipsen S.A.: Key Facts
Ipsen S.A.: Key Employees
Ipsen S.A.: Key Employee Biographies
Ipsen S.A.: Major Products and Services
Ipsen S.A.: Management Statement
Ipsen S.A.: Locations and Subsidiaries
Ipsen S.A.: Key Competitors
Ipsen S.A.: Company Analysis
Ipsen S.A.: Business Description
Ipsen S.A.: SWOT Analysis
Ipsen S.A.: SWOT Overview
Ipsen S.A.: Strengths
Ipsen S.A.: Weaknesses
Ipsen S.A.: Opportunities
Ipsen S.A.: Threats
Ipsen S.A.: Corporate Financial Deals Activity
Ipsen S.A.: Financial Deals Overview
Ipsen S.A.: Targets and Partners
Ipsen S.A.: Top Deals 2020 - 2024YTD*
Ipsen S.A.: Advisors
Ipsen S.A.: Top Legal Advisors
Ipsen S.A.: Top Financial Advisors
Ipsen S.A.: Mergers and Acquisitions
Ipsen S.A.: Corporate Venturing
Ipsen S.A.: Partnership
Ipsen S.A.: Divestments
Ipsen S.A.: Recent Developments
Ipsen S.A.: News and Events Summary
Ipsen S.A.: Financial Deals
Ipsen S.A.: Financial Performance
Ipsen S.A.: Market Developments
Ipsen S.A.: Regulatory and Legal Events
Ipsen S.A.: Research & Development
Ipsen S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Ipsen S.A.: Key Facts
Table 2: Ipsen S.A.: Key Employees
Table 3: Ipsen S.A.: Locations and Subsidiaries
Table 4: Ipsen S.A.: Key Competitors
Table 5: Ipsen S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ipsen S.A.: M&A Activity by Geography (TTM*)
Table 7: Ipsen S.A.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 8: Ipsen S.A.: M&A Average Deal Size - Value (US$m)
Table 9: Ipsen S.A.: Targets and Partners
Table 10: Ipsen S.A.: Top Deals 2020 - 2024YTD*
Table 11: Ipsen S.A.: Legal Advisor Ranking by Value (US$m)
Table 12: Ipsen S.A.: Financial Advisor Ranking by Value (US$m)
Table 13: Ipsen S.A.: M&A Volume and Value Trend (2020 - YTD*2024)